Clinical Trials Logo

Filter by:
NCT ID: NCT03466398 Withdrawn - Diabetes Mellitus Clinical Trials

Effects of a Remote Patient Monitoring Protocol on Glycemic Control in Adolescents With Type 1 Diabetes

Start date: April 11, 2018
Phase: N/A
Study type: Interventional

This study will use a randomized, crossover design. Children aged 13-18 years who have been diagnosed with Type 1 diabetes for at least 1 year and with at least 2 Hemoglobin A1c values ≥10.0% more than 60 days apart within the past year, with the most recent HbA1c value between 10-14%, will be placed into two separate treatment groups. Group A will undergo home monitoring for 12 weeks through the use of the Vivify kit, which contains a wireless tablet with daily medication/diet/symptom questionnaires. Group B will initially continue diabetes management per standard of care, including quarterly office visits. After a period of 12 weeks, Group B will switch to the RPM protocol, while Group A will return to standard of care. Both groups will have HbA1c values checked at the 0, 3, and 6 month time periods to assess the effect of the remote monitoring protocol. Participation in the RPM protocol will involve daily completion of the Care Plan questions, as well as weekly uploads of blood glucose values using the Glooko, Inc (Mountain View, CA) application, and weekly video visits with a member of the endocrinology team that will aim to address barriers to optimal care, whether they be motivation, knowledge or other difficulties. Barriers to care will be assessed in part through the completion of knowledge and self-efficacy assessments.

NCT ID: NCT03504033 Withdrawn - Clinical trials for Liver Function After Partial Liver Resection

Xenon-anesthesia on Patients Undergoing Major Liver-resection

XeLiv
Start date: April 11, 2018
Phase: Phase 4
Study type: Interventional

The aim of this study is to compare the postoperative outcome of patients undergoing major liver resection under xenon- compared to desflurane-anesthesia.

NCT ID: NCT03898973 Withdrawn - Influenza Clinical Trials

Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood

FLU-LN
Start date: April 11, 2019
Phase: Phase 4
Study type: Interventional

This is one project of a larger ongoing study related to the immune system's response to the flu virus. This study is designed to determine how immune memory develops at the actual site of exposure, and how immunization may alter this process.

NCT ID: NCT03667443 Withdrawn - PCOS Clinical Trials

Myo-inositol Plus Alpha-lactalbumin in PCOS Myo-inositol-resistant Patients

Start date: April 11, 2022
Phase: N/A
Study type: Interventional

The investigator's aim is to evaluate if the combination of myo-inositol and alpha-lactalbumin can overcome the resistance to myo-inositol in PCOS patients

NCT ID: NCT03455777 Withdrawn - Clinical trials for Homozygous Familial Hypercholesterolemia

Study of AKCEA-ANGPTL3-LRX (ISIS 703802) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)

Start date: April 12, 2018
Phase: Phase 2
Study type: Interventional

This is a single center, open-label study to evaluate the efficacy of AKCEA-ANGPTL3- LRX for reduction of low density lipoprotein cholesterol (LDL-C) levels in patients with Homozygous Familial Hypercholesterolemia (HoFH).

NCT ID: NCT03509298 Withdrawn - Clinical trials for Advanced Pancreatic Cancer

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer

Start date: April 12, 2018
Phase: Phase 2
Study type: Interventional

This is a phase II Randomized comparison clinical trial of activated CIK armed with anti-CD3-MUC1 bispecific antibody for advanced pancreatic cancer. And the aim of this research is to study the clinical efficacy and safety of activated CIK armed with anti-CD3-MUC1 bispecific antibody for pancreatic cancer.

NCT ID: NCT03788889 Withdrawn - Clinical trials for Alcohol Withdrawal Syndrome

Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine

PKAT
Start date: April 12, 2019
Phase: Phase 4
Study type: Interventional

The goal of this study will aim to determine if adding phenobarbital or ketamine to a symptom-triggered benzodiazepine regimen decreases the rate of intensive care unit admissions during the treatment of alcohol withdrawal syndrome when compared to symptom-triggered benzodiazepine therapy alone.

NCT ID: NCT03989076 Withdrawn - Clinical trials for IVC - Inferior Vena Cava Abnormality

Inferior Vena Cava (IVC) Diameters Before & After Interscalene Block

Start date: April 12, 2019
Phase:
Study type: Observational

The purpose of this study is to understand how changes to breathing patterns in the chest affect blood flow to the heart from the inferior vena cava in the abdomen. Ultrasound of the upper abdomen will be used to visualize changes in breathing patterns in the chest and blood flow in the abdomen.

NCT ID: NCT04938128 Withdrawn - Clinical trials for Sleep Apnea, Obstructive

Effect of CPAP vs Control on Nocturnal Dipping in Normotensive Patients With Obstructive Sleep Apnea

Start date: April 12, 2021
Phase: N/A
Study type: Interventional

This is an open-label, parallel, prospective, randomised control trial evaluating the effect of Continuous Positive airway pressure (CPAP), the standard treatment for obstructive sleep apnea (OSA) versus control (diet and lifestyle advice) on dipping status and blood pressure parameters in 100 non-dipper normotensive patients with moderate to severe obstructive sleep apnea and without established cardiovascular or metabolic disease.

NCT ID: NCT05156463 Withdrawn - Breast Cancer Clinical Trials

The PAI Trial for Breast and Colon Cancer Survivors

Start date: April 12, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if a Physical Activity Index (PAI) tool that collects measures on physical activity, strength training and sedentary behavior can be used in a clinical setting to monitor patient behavior and provide specific recommendations on how to achieve and maintain behavior goals. The tool will be used after treatment is completed in breast and colon cancer survivors and will test if physician counseling combined with patient self-monitoring improves physical activity and reduces sedentary behavior over time.